The FDA said some of Boston Scientific ’s Endotak Reliance defibrillator wires can become calcified, which may stop the ...

U.S. health regulators are warning doctors and patients about safety issues with two separate Boston Scientific heart devices ...

A company spokesperson said in a statement to MedTech Dive that direct causation between the deaths and calcification of the ...

Boston Scientific (BSX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to ...

When considering lead replacement, physicians should weigh the risks and benefits of extraction versus abandonment.

Boston Scientific has launched Endura Weight Loss Solutions, alongside survey findings showing that many U.S. women are ...

This was the stock's second consecutive day of gains.

Boston Scientific warned of the potential for rising low-voltage shock impedance (LVSI) associated with Reliance ...

Marlborough, Mass.-based Boston Scientific has launched Endura Weight Loss Solutions, a new line of minimally invasive endobariatric procedures such as endoscopic sleeve gastroplasty and Orbera ...

The current consensus estimates for BSX's forthcoming earnings report stand at $0.72 per share on revenue of $4.89 billion.

Boston Scientific bumped up its financial forecasts for the remainder of this year after reporting double-digit growth across ...

Boston Scientific’s revenues rose from $18.4 billion in 2019 to $20.2 billion in 2022, driven by an uptick in total procedures after a decline during the pandemic period.